HRP20080452T3 - Orally disintegrating pharmaceutical composition comprising risperidone - Google Patents

Orally disintegrating pharmaceutical composition comprising risperidone

Info

Publication number: HRP20080452T3
Authority: HR; Croatia
Prior art keywords: risperidone; pharmaceutical composition; orally disintegrating; disintegrating pharmaceutical; orally
Prior art date: 2004-06-15

Application number

HR20080452T

Other languages

English (en)

Croatian (hr)

Inventor

Kroselj Vesna

Rajer Tadeja

Rangus Marija

Gustin Jozica

Original Assignee

Krka

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-15

Filing date

2008-09-17

Publication date

2008-10-31

2008-09-17 Application filed by Krka filed Critical Krka

2008-10-31 Publication of HRP20080452T3 publication Critical patent/HRP20080452T3/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 title abstract 2
229960001534 risperidone Drugs 0.000 title abstract 2
238000005469 granulation Methods 0.000 abstract 1
230000003179 granulation Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229920000193 polymethacrylate Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Psychiatry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

HR20080452T 2004-06-15 2008-09-17 Orally disintegrating pharmaceutical composition comprising risperidone HRP20080452T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004028940A DE102004028940A1 (de)	2004-06-15	2004-06-15	Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
PCT/EP2005/006375 WO2005123084A1 (en)	2004-06-15	2005-06-14	Orally disintegrating pharmaceutical composition comprising risperidone

Publications (1)

Publication Number	Publication Date
HRP20080452T3 true HRP20080452T3 (en)	2008-10-31

Family

ID=34971693

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20080452T HRP20080452T3 (en)	2004-06-15	2008-09-17	Orally disintegrating pharmaceutical composition comprising risperidone

Country Status (13)

Country	Link
EP (1)	EP1768673B1 (pl)
AT (1)	ATE402706T1 (pl)
DE (2)	DE102004028940A1 (pl)
EA (1)	EA010178B1 (pl)
ES (1)	ES2311230T3 (pl)
HR (1)	HRP20080452T3 (pl)
NO (1)	NO20070187L (pl)
PL (1)	PL1768673T3 (pl)
PT (1)	PT1768673E (pl)
RS (1)	RS50609B (pl)
SI (1)	SI1768673T1 (pl)
UA (1)	UA87692C2 (pl)
WO (1)	WO2005123084A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080085310A1 (en) *	2006-10-06	2008-04-10	Maria Oksana Bachynsky	Capecitabine rapidly disintegrating tablets
TW200835527A (en) *	2006-12-26	2008-09-01	Shionogi & Co	Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
CN101269014B (zh) *	2007-03-21	2012-11-14	江苏万特制药有限公司	一种利培酮的口腔崩解片及其制备方法
WO2008152729A1 (ja) *	2007-06-15	2008-12-18	Teikokumedix Co., Ltd.	リスペリドンを含むゼリー状の医薬組成物
CN101485636B (zh) *	2008-01-14	2010-12-22	齐鲁制药有限公司	利培酮口腔崩解片及其制备方法
WO2013095314A1 (en) *	2011-12-19	2013-06-27	Mahmut Bilgic	Pharmaceutical formulations comprising risperidone
WO2013100876A1 (en) *	2011-12-27	2013-07-04	Mahmut Bilgic	Risperidone formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0910345B1 (en) *	1996-06-17	2002-02-13	Janssen Pharmaceutica N.V.	Biconvex rapidly disintegrating dosage forms
US7919119B2 (en) *	1999-05-27	2011-04-05	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) *	1999-05-27	2002-05-28	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
MXPA03000985A (es) *	2001-07-27	2004-04-02	Yamanouchi Pharma Co Ltd	Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
AU2004238321B2 (en) *	2003-05-07	2009-08-27	Samyang Biopharmaceuticals Corporation	Highly plastic granules for making fast melting tablets
WO2005120463A1 (en) *	2004-06-09	2005-12-22	Ranbaxy Laboratories Limited	Rapidly disintegrating tablets of risperidone

2004
- 2004-06-15 DE DE102004028940A patent/DE102004028940A1/de not_active Withdrawn
2005
- 2005-06-14 UA UAA200700399A patent/UA87692C2/ru unknown
- 2005-06-14 RS RSP-2008/0419A patent/RS50609B/sr unknown
- 2005-06-14 AT AT05757277T patent/ATE402706T1/de not_active IP Right Cessation
- 2005-06-14 PT PT05757277T patent/PT1768673E/pt unknown
- 2005-06-14 EA EA200700023A patent/EA010178B1/ru not_active IP Right Cessation
- 2005-06-14 SI SI200530422T patent/SI1768673T1/sl unknown
- 2005-06-14 ES ES05757277T patent/ES2311230T3/es active Active
- 2005-06-14 DE DE602005008607T patent/DE602005008607D1/de active Active
- 2005-06-14 EP EP05757277A patent/EP1768673B1/en active Active
- 2005-06-14 PL PL05757277T patent/PL1768673T3/pl unknown
- 2005-06-14 WO PCT/EP2005/006375 patent/WO2005123084A1/en active Application Filing
2007
- 2007-01-11 NO NO20070187A patent/NO20070187L/no not_active Application Discontinuation
2008
- 2008-09-17 HR HR20080452T patent/HRP20080452T3/xx unknown

Also Published As

Publication number	Publication date
RS50609B (sr)	2010-06-30
DE602005008607D1 (de)	2008-09-11
UA87692C2 (ru)	2009-08-10
EP1768673A1 (en)	2007-04-04
ATE402706T1 (de)	2008-08-15
EP1768673B1 (en)	2008-07-30
DE102004028940A1 (de)	2006-01-12
PL1768673T3 (pl)	2009-01-30
NO20070187L (no)	2007-03-02
PT1768673E (pt)	2008-10-21
EA010178B1 (ru)	2008-06-30
SI1768673T1 (sl)	2008-12-31
EA200700023A1 (ru)	2007-06-29
ES2311230T3 (es)	2009-02-01
WO2005123084A1 (en)	2005-12-29

Similar Documents

Publication	Publication Date	Title
MX2009001294A (es)	2009-05-21	Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
TW200744602A (en)	2007-12-16	Administration of dipeptidyl peptidase inhibitors
HRP20080452T3 (en)	2008-10-31	Orally disintegrating pharmaceutical composition comprising risperidone
MX2009002772A (es)	2009-05-28	Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo.
AP2007003973A0 (en)	2007-07-30	Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation
MY157661A (en)	2016-07-15	Bendamustine pharmaceutical compositions
UA90875C2 (ru)	2010-06-10	Лекарственные формы пролонгированного действия, которые содержат ранолазин
SG153800A1 (en)	2009-07-29	Pharmaceutical compositions
MX2008001799A (es)	2008-04-16	Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
GEP20094679B (en)	2009-05-10	Dipeptidyl peptidase inhibitors
TNSN08178A1 (en)	2009-10-30	Triazolopyridine derivatives as inhibitors of lipases and phospholipases
ZA200806778B (en)	2009-11-25	N-Hydroxyacrylamide compounds
MX343358B (es)	2016-11-03	Tabletas de acetato de ulipristal.
MX2007001953A (es)	2007-05-09	Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
GEP20125458B (en)	2012-03-26	Matrix metalloproteinase inhibitors
PL382842A1 (pl)	2008-01-21	Sole donepezilu odpowiednie do otrzymywania kompozycji farmaceutycznych
UA94036C2 (ru)	2011-04-11	Фармацевтическая композиция бендамустина, предназначенная для лиофилизации
TW200738649A (en)	2007-10-16	Calcilytic compounds
ZA200604874B (en)	2007-03-28	Pharmaceutical compositions
TW200730190A (en)	2007-08-16	New combination to treat liver fibrosis
MY149864A (en)	2013-10-31	Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
MX2009003755A (es)	2009-07-10	Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato.
WO2006005578A3 (en)	2006-06-08	Solid pharmaceutical composition comprising mirtazapine
MX2009005804A (es)	2009-09-24	Composicion farmaceutica de memantina.
IL191992A0 (en)	2008-12-29	Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications